Raynaud's phenomenon: Diagnosis and treatment;Phenomenes de raynaud: Enquete diagnostique et traitement

Revue du Praticien

Volumn 48, Issue 15, 1998, Pages 1659-1664

  Priollet, Pascal ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULINEMIA; FINGER BLOOD FLOW; FRANCE; HASHIMOTO DISEASE; HUMAN; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; VASOMOTOR REFLEX; CAPILLARY; FINGER; SYSTEMIC SCLEROSIS; VASCULARIZATION;

CAPILLARIES; FINGERS; HUMANS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 0032187242     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Coffman JD. Raynaud's phenomenon. An update. Hypertension 1991 ; 17 : 593-602.
2. Mourad JJ, Priollet P, Girerd X et al. The wall to lumen ratio of the radial artery in patients with Raynaud's phenomenon. J Vasc Res 1997 ; 34 : 298-305.
3. Rodnan G, Myerowitz RL, Justh GO. Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon. Medicine 1980 ; 59 : 393-408.
4. Maricq HR, Carpentier PH, Weinrich MC et al. Geographic variation in the prevalence of Raynaud's phenomenon : Charleston, SC, USA, US Tarentaise, Savoie, France. J Rheumatol 1993 ; 20 : 70-7.
5. Valter I, Maricq HR. Prevalence of Raynaud's phenomenon in Tartu and Tartumaa, Southern Estonia. Scand J Rheum 1997 ; 76 : 117-24.
6. Riera G, Vilardell M, Vaqué J et al. Prevalence of Raynaud's phenomenon in a healthy Spanish population. J Rheumatol 1993 ; 20 : 66-9.
7. Priollet P. Acrosyndromes. Editions Techniques. Encycl Med Chir (Paris-France),Thérapeutique, 25-347-A-10, 1993, 10 pp.
8. Priollet P, Vayssairat M, Housset E. How to classify Raynaud's phenomenon ? Long term follow-up study of 73 cases. Am J Med 1987 ; 83 : 494-8.
9. Rodnan GP, MedsgerTA Jr, Buckingham RB. Progressive systemic sclerosis-CREST-syndrome :Observations on natural history and late complications in 90 patients (abstract). Arthritis Rheum 1975 ; 18 :423.
10. Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med 1989; 11 : 377-83.
11. Vayssairat M, Debure C, Cormier JM, Bruneval P, Lauriant C, Juillet Y. Hypothenar hammer syndrome : seventeen cases with long-term follow-up. J Vase Surg 1987 ; 5 : 838-43.
12. Priollet P, Yeni P, Vayssairat M, Segond P. Tallon F, Housset E. Bilan étiologique minimum des phénomènes de Raynaud. Cent deux cas. Presse Med 1985 ; 39 : 1999-2003.
13. Masi AT, Rodnan GP, Medser TA Jr et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 ; 23 : 581-90.
14. Le Roy EC, Medsger TA. Raynaud's phenomenon : a proposal for classification. Clin Experiment Rheumatol 1992 ; 10 : 485-8.
15. Navon P, Yarom A, Davis E. Raynaud's features in childhood. J Mal Vasc (Paris) 1992 ; 17 : 273-6.
16. Kahl LE, Blair C, Ramsey-Goldman R et al. Pregnancy outcomes in women with primary Raynaud's phenomenon. Arthritis Rheum 1990 ; 3 : 1249-55.
17. Priollet P, Lazareth I. Traitement des phénomènes de Raynaud sévères. Sang Thromb Vaiss 1996 ; 8 : 575-80.
18. Belch JJF, Meilien H. Pharmacotherapy of Raynaud's phenomenon. Drugs 1996 ; 52 : 682-95.
19. French Cooperative Multicenter Group for Raynaud Phenomenon. Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud's phenomenon. Am Heart J 1991 ; 122 : 352-5.
20. Palmieri GMA, Sebes JI, Aelion JA et al. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995 ; 38 : 1646-54.
21. O'Keeffe ST, Tsapatsaris NP, Betham WP. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 1992 ; 116 : 985-9.
22. Yeh LS, Manning J, Moore T et al. Sustained-release transdermal glyceryl trinitrate patches as a treatment or primary and secondary Raynaud's phenomenon. Br J Rheum 1995 ; 34 : 636-41.
23. Wigler FM, Wise RA, Seibold JR et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994 ; 120 : 199-296.
24. Vayssairat M and the French microcirculation Society Multicentre Group for the study of vascular acrosyndromes. Controlled multicenter double-blind trial of an oral analog of Prostacyclin in the treatment of primary Raynaud's phenomenon. J Rheum 1996 ; 23 : 1917-20.
25. Bunker CB, Reavley C, O'Shaughnessy DJ, Dowd PM. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. Lancet 1993 ; 342 : 80-3.
26. Ahs SS, Machleder HI, Concepsion B, Moore WS. Thoracoscopic cervicodorsal sympathectomy : preliminary results. J Vasc Surg 1994 ; 20 : 511-7.
27. Nicholson ML, Dennis MJ, Hopkinson BR. Endoscopic transthoracic symathectomy : successful in hyperhidrosis but can the indications be extended ? Ann R Coll Surg Engl 1994 ; 76 : 311-4.